Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChurchill China Regulatory News (CHH)

Share Price Information for Churchill China (CHH)

Share Price is delayed by 15 minutes
Get Live Data
340.00    0.00 (0.00%)
Bid:
330.00
Ask:
350.00
Spread: 20.00 (6.061%)
Market Cap: £37.39m
CHH Live PriceLast checked at - London Stock Exchange

Intraday Churchill China Share Chart

FCA Results Moratorium and COVID-19 Update

24 Mar 2020 12:41

RNS Number : 3973H
Churchill China PLC
24 March 2020
 

For immediate release

24 March 2020

 

 

 

 

 

 

CHURCHILL CHINA plc

("Churchill China" or the "Company")

 

FCA Results Moratorium and COVID-19 update

 

Churchill China plc (AIM: CHH), the manufacturer of innovative performance ceramic products serving hospitality markets worldwide, makes the following announcement.

The Financial Conduct Authority (FCA) and Financial Reporting Council (FRC) have issued guidance asking public companies to delay the release of Preliminary Results for at least two weeks. Accordingly Churchill China will delay the release of its Preliminary Results for the year ended 31 December 2019, originally scheduled on Thursday 26 March 2020. The Company will await further guidance from the FCA with regard to the timing of the publication of its Preliminary Results.

In advance of the issue of the Company's audited Preliminary Results, we today release the following unaudited financial information for the year to 31 December 2019, which confirms a strong performance during the year.

Revenue: £67.5m (2018: £57.5m)

Profit before income tax: £11.3m, including exceptional credits of £0.1m (2018: £8.9m after exceptional costs of £0.5m).

Net cash and deposits: (excluding lease liabilities) £15.6m (2018: £17.4m).

 

COVID-19

The hospitality sector we serve has already been affected by COVID-19 and the level of impact on Churchill's operations remains uncertain. Management has acted quickly to develop and implement plans aimed at preserving the safety of our employees and the long term health of the business. These contingency plans have focussed on significantly reducing the cash cost of our operations in the short term.

Substantially the largest part of Churchill's cost base is represented by direct materials, manpower and energy costs. Recent announcements in relation to Government support for employment will facilitate this cost reduction programme and we have taken the decision to temporarily suspend manufacturing operations until the business environment is clearer. This will significantly reduce our cost of operation without impacting customer service levels which will be fulfilled from existing inventory.

The Company has a positive cash position and a strong balance sheet. We retain the ability to act quickly to actively manage cash outflows in the short and medium term.

Owing to the evolving COVID-19 position and consequent lack of visibility, no formal guidance will be given on future financial performance until further notice.

 

For further information, please contact:

 

Churchill China plc

Tel: 01782 577566

David O'Connor / David Taylor

Buchanan

Tel: 020 7466 5000

Mark Court / Charlotte Slater

Investec Bank plc

David Flin / Alex Wright / David Anderson

Tel: 020 7597 5970

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSOURRKUOUAR
Date   Source Headline
17th Jun 20267:00 amRNSChange of Auditor
29th May 20265:35 pmRNSResults of AGM
29th May 20267:00 amRNSAGM Statement
20th May 20262:45 pmRNSGrant of Options under LTIP
30th Apr 20264:40 pmRNSPosting of Annual Report and Notice of AGM
20th Apr 20267:00 amRNSDirector dealing
17th Apr 20264:21 pmRNSDirector dealing – Late Notification
15th Apr 20264:13 pmRNSNotification of Major Holdings
13th Apr 20267:00 amRNSFinal Results
1st Apr 20267:00 amRNSNotification of Final Results
26th Mar 20262:08 pmRNSNotification of Major Holdings
24th Feb 20265:31 pmRNSNotification of Major Holdings
2nd Feb 20267:00 amRNSFull Year Trading Update 2025
23rd Oct 20252:48 pmRNSDirector Dealing
21st Oct 20251:10 pmRNSNotification of Major Holdings
3rd Sep 20257:00 amRNSInterim Results
11th Aug 20257:00 amRNSNotification of Interim Results
17th Jul 20255:33 pmRNSNotification of Major Holdings
17th Jul 20257:00 amRNSTrading Update
20th Jun 20253:39 pmRNSGrant of Options under LTIP
30th May 20251:02 pmRNSNotification of Major Holdings
29th May 20254:01 pmRNSResult of AGM
29th May 20257:00 amRNSAGM Statement
22nd May 20252:29 pmRNSNotification of Major Holdings
7th May 20254:20 pmRNSPosting of Annual Report and Notice of AGM
15th Apr 20252:22 pmRNSDividend Declaration
9th Apr 20257:00 amRNSFinal Results
26th Mar 20257:01 amRNSNotification of Final Results
26th Mar 20257:00 amRNSAppointment of Joint Broker
18th Mar 20253:19 pmRNSNotification of Major Holdings
12th Mar 20255:00 pmRNSNotification of Major Holdings
3rd Feb 20257:00 amRNSFull Year Trading Update
17th Jan 20255:50 pmRNSNotification of Major Holdings
5th Dec 20243:08 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTrading Update
17th Oct 20246:03 pmRNSDirector/PDMR Shareholding
14th Oct 20241:51 pmRNSNotification of Major Holdings
11th Oct 20243:13 pmRNSPDMR/Substantial Shareholding Dealing
5th Sep 20247:00 amRNSInterim Results
6th Aug 20244:21 pmRNSNotification of Major Holdings
24th Jul 20247:00 amRNSHalf Year Trading Update and Notice of Results
5th Jun 20242:35 pmRNSResult of AGM
5th Jun 20247:00 amRNSAGM Statement
24th May 20245:30 pmRNSGrant of Options under LTIP
10th May 20244:45 pmRNSNotification of Major Holdings
10th May 202410:30 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20245:57 pmRNSDirector Dealing
30th Apr 20245:53 pmRNSDirector Dealing
16th Apr 20249:46 amRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.